MicroMed Cardiovascular Inc. announced that Ash Attia has joined the company as Vice President of Asia-Pacific. Attia will be responsible for the launch, management and expansion of the HeartAssist 5 in the region, which includes China, Japan, India, Southeast Asia, Australia and New Zealand. Attia held the position of Vice President of Asia-Pacific for Ventracor Limited.

MicroMed Cardiovascular Inc. announced that Danny Bluestein joined the science advisory board to provide industry expertise and guidance for the HeartAssist 5(TM) ventricular assist device, The Modern DeBakey VAD(TM). Bluestein joins other world-renowned members of MicroMed's SAB, including transplant surgeon George Noon, MD, co-inventor of the HeartAssist 5, Dr. Marvin Slepian, director of Interventional Cardiology at the University of Arizona and Matthias Loebe, MD, PhD, professor at Baylor College of Medicine in Texas.

On July 23, MicroMed Cardiovascular Inc. announced the creation of its Science Advisory Board (SAB), led by new Chairman Marvin Slepian, MD, to provide scientific support and guidance related to its HeartAssist 5(TM) ventricular assist device, The Modern DeBakey VAD(TM). Dr. Slepian is Professor of Medicine (Cardiology), Director of Interventional Cardiology and Director of the Tissue Engineering Lab at the University of Arizona. He is also the co-founder, Chief Medical & Scientific Officer and Chairman of the Board for SynCardia Systems Inc.